Literature DB >> 33418990

The LDLR, APOB, and PCSK9 Variants of Index Patients with Familial Hypercholesterolemia in Russia.

Alexey Meshkov1, Alexandra Ershova1, Anna Kiseleva1, Evgenia Zotova2, Evgeniia Sotnikova1, Anna Petukhova2, Anastasia Zharikova1,3, Pavel Malyshev4, Tatyana Rozhkova4, Anastasia Blokhina1, Alena Limonova1, Vasily Ramensky1,3, Mikhail Divashuk1, Zukhra Khasanova4, Anna Bukaeva2, Olga Kurilova1, Olga Skirko1, Maria Pokrovskaya1, Valeriya Mikova2, Ekaterina Snigir2, Alexsandra Akinshina2, Sergey Mitrofanov2, Daria Kashtanova2, Valentin Makarov2, Valeriy Kukharchuk4, Sergey Boytsov4, Sergey Yudin2, Oxana Drapkina1.   

Abstract

Familial hypercholesterolemia (FH) is a common autosomal codominant disorder, characterized by elevated low-density lipoprotein cholesterol levels causing premature atherosclerotic cardiovascular disease. About 2900 variants of LDLR, APOB, and PCSK9 genes potentially associated with FH have been described earlier. Nevertheless, the genetics of FH in a Russian population is poorly understood. The aim of this study is to present data on the spectrum of LDLR, APOB, and PCSK9 gene variants in a cohort of 595 index Russian patients with FH, as well as an additional systematic analysis of the literature for the period of 1995-2020 on LDLR, APOB and PCSK9 gene variants described in Russian patients with FH. We used targeted and whole genome sequencing to search for variants. Accordingly, when combining our novel data and the data of a systematic literature review, we described 224 variants: 187 variants in LDLR, 14 variants in APOB, and 23 variants in PCSK9. A significant proportion of variants, 81 of 224 (36.1%), were not described earlier in FH patients in other populations and may be specific for Russia. Thus, this study significantly supplements knowledge about the spectrum of variants causing FH in Russia and may contribute to a wider implementation of genetic diagnostics in FH patients in Russia.

Entities:  

Keywords:  APOB; LDLR; PCSK9; Russian; familial hypercholesterolemia; whole genome sequencing

Mesh:

Substances:

Year:  2021        PMID: 33418990      PMCID: PMC7825309          DOI: 10.3390/genes12010066

Source DB:  PubMed          Journal:  Genes (Basel)        ISSN: 2073-4425            Impact factor:   4.096


  32 in total

1.  [Identification of novel missense mutation G571E, novel silent mutation H229H, nonsense mutation C74X, and four single nucleotide polymorphisms in the low-density lipoprotein receptor in patients with familial hypercholesterolemia from St. Petersburg].

Authors:  F M Zakharova; V I Golubkov; M Iu Mandel'shtam; B M Lipovetskiĭ; V S Gaĭtskhoki
Journal:  Bioorg Khim       Date:  2001 Sep-Oct

2.  [Genetic factors of risk of ischemic heart disease development in patients with familial hypercholesterolemia].

Authors:  A N Meshkov; D V Stambol'skiĭ; L A Nikitina; S M Abdullaev; V N Bochkov; V A Tkachuk; V V Kukharchuk; P P Malyshev
Journal:  Kardiologiia       Date:  2005       Impact factor: 0.395

3.  ClinVar database of global familial hypercholesterolemia-associated DNA variants.

Authors:  Michael A Iacocca; Joana R Chora; Alain Carrié; Tomáš Freiberger; Sarah E Leigh; Joep C Defesche; C Lisa Kurtz; Marina T DiStefano; Raul D Santos; Steve E Humphries; Pedro Mata; Cinthia E Jannes; Amanda J Hooper; Katherine A Wilemon; Pascale Benlian; Robert O'Connor; John Garcia; Hannah Wand; Lukáš Tichy; Eric J Sijbrands; Robert A Hegele; Mafalda Bourbon; Joshua W Knowles
Journal:  Hum Mutat       Date:  2018-11       Impact factor: 4.878

4.  Worldwide Prevalence of Familial Hypercholesterolemia: Meta-Analyses of 11 Million Subjects.

Authors:  Sabina O Beheshti; Christian M Madsen; Anette Varbo; Børge G Nordestgaard
Journal:  J Am Coll Cardiol       Date:  2020-05-26       Impact factor: 24.094

5.  [Familial hypercholesterolemia due to a new mutation in the low density lipoprotein receptor gene].

Authors:  V A Korneva; T Iu Bogoslovskaia; T Iu Kuznetsova; M Iu Mandel'shtam; V B Vasil'ev
Journal:  Klin Med (Mosk)       Date:  2014

6.  [Familial hypercholesterolemia in St. Petersburg: diversity of mutations argues against a strong founder effect].

Authors:  F M Zakharova; Iu A Tatishcheva; V I Golubkov; B M Lipovetskiĭ; V O Konstantinov; A D Denisenko; O Faergeman; V B Vasil'ev; M Iu Mandel'shtam
Journal:  Genetika       Date:  2007-09

7.  Two novel low-density lipoprotein receptor gene mutations (E397X and 347delGCC) in St. Petersburg familial hypercholesterolemia.

Authors:  K Chakir; C Kh; M M Ju; S P Shevtsov; V I Golubkov; N A Skobeleva; Y A Shur; F M Zakharova; B M Lipovetskyi; V O Konstantinov; A D Denisenko; V S Gaitskhoki; E I Schwartz
Journal:  Mol Genet Metab       Date:  1998-12       Impact factor: 4.797

8.  Integrative genomics viewer.

Authors:  James T Robinson; Helga Thorvaldsdóttir; Wendy Winckler; Mitchell Guttman; Eric S Lander; Gad Getz; Jill P Mesirov
Journal:  Nat Biotechnol       Date:  2011-01       Impact factor: 54.908

9.  Cholesterol Levels in Genetically Determined Familial Hypercholesterolaemia in Russian Karelia.

Authors:  V A Korneva; T Yu Kuznetsova; T Yu Bogoslovskaya; D S Polyakov; V B Vasilyev; A V Orlov; M Yu Mandelshtam
Journal:  Cholesterol       Date:  2017-03-28

10.  Verification of Underlying Genetic Cause in a Cohort of Russian Patients with Familial Hypercholesterolemia Using Targeted Next Generation Sequencing.

Authors:  Anna E Semenova; Igor V Sergienko; Diego García-Giustiniani; Lorenzo Monserrat; Anna B Popova; Diana N Nozadze; Marat V Ezhov
Journal:  J Cardiovasc Dev Dis       Date:  2020-05-14
View more
  4 in total

1.  Special Issue "Cardiovascular Genetics".

Authors:  Andreas Brodehl; Hendrik Milting; Brenda Gerull
Journal:  Genes (Basel)       Date:  2021-03-26       Impact factor: 4.096

Review 2.  Relationship between Brain Metabolic Disorders and Cognitive Impairment: LDL Receptor Defect.

Authors:  Dong-Yong Hong; Dong-Hun Lee; Ji-Young Lee; Eun-Chae Lee; Sang-Won Park; Man-Ryul Lee; Jae-Sang Oh
Journal:  Int J Mol Sci       Date:  2022-07-29       Impact factor: 6.208

3.  The Prevalence and Genetic Spectrum of Familial Hypercholesterolemia in Qatar Based on Whole Genome Sequencing of 14,000 Subjects.

Authors:  Ilhame Diboun; Yasser Al-Sarraj; Salman M Toor; Shaban Mohammed; Nadeem Qureshi; Moza S H Al Hail; Amin Jayyousi; Jassim Al Suwaidi; Omar M E Albagha
Journal:  Front Genet       Date:  2022-07-15       Impact factor: 4.772

4.  Phenotypic vs. genetic cascade screening for familial hypercholesterolemia: A case report.

Authors:  Anastasia V Blokhina; Alexandra I Ershova; Alexey N Meshkov; Anna V Kiseleva; Marina V Klimushina; Anastasia A Zharikova; Evgeniia A Sotnikova; Vasily E Ramensky; Oxana M Drapkina
Journal:  Front Cardiovasc Med       Date:  2022-08-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.